Business Context and Reporting Period
This Form 8-K is a current report filed by Houston American Energy Corp. (not Abundia Global Impact Group, Inc.) on June 4, 2008, covering events that occurred on June 2, 2008, during the company's 2008 Annual Meeting of Stockholders.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The report focuses exclusively on corporate governance and executive compensation actions.
Material Changes and Executive Actions
- Equity Incentive Plan Adoption: Stockholders approved the 2008 Equity Incentive Plan, reserving 2,200,000 shares of common stock for issuance via stock options, restricted stock, and stock appreciation rights.
- CFO Compensation Adjustment: The Compensation Committee approved a base salary increase for CFO Jay Jacobs to $165,000, effective July 1, 2008.
- Stock Option Grants:
- CEO John Terwilliger: Granted options to purchase 900,000 shares at $7.20/share (10-year term, 6-year vesting). No additional equity grants permitted for 3 years.
- CFO Jay Jacobs: Granted options to purchase 150,000 shares at $7.20/share (10-year term, 3-year vesting).
- Restricted Stock Grants: Stockholders approved previously pending restricted stock grants of 41,700 shares to Mr. Terwilliger and 13,900 shares to Mr. Jacobs, subject to a one-year vesting period.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The document is limited to the disclosure of the equity plan adoption and specific officer compensation adjustments.
Investor Verification Checklist
- Verify the total number of shares reserved under the new 2008 Equity Incentive Plan (2,200,000) against the company's current authorized share count.
- Confirm the exercise price of $7.20 per share relative to the market price on June 2, 2008.
- Review the definitive proxy statement filed on April 28, 2008, for the full text of the Equity Incentive Plan.
- Monitor the vesting schedules for the new option and restricted stock grants to assess future dilution.